3
Announcements
Trials
Browse
Landscape
Status
Completed
6
Recruiting
4
Terminated
2
Withdrawn
1
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Conditions
Eunuchism
2
Sarcopenia
1
Prostatic Neoplasms
1
Osteoporosis
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Metabolic Syndrome
1
Metabolic Diseases
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Arthralgia
1
Interventions
Docetaxel
21
Radiosurgery
19
Radiotherapy
17
Androgen Antagonists
14
Leuprolide
11
Goserelin
11
bicalutamide
9
enzalutamide
8
Surveys and Questionnaires
8
Prednisone
8
Brachytherapy
8
Blood Specimen Collection
8
Abiraterone Acetate
8
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
7
Radiotherapy, Intensity-Modulated
7
Multiparametric Magnetic Resonance Imaging
7
Gonadotropin-Releasing Hormone
7
Triptorelin Pamoate
6
pembrolizumab
4
cabazitaxel
4
abiraterone
4
Standard of Care
4
Positron Emission Tomography Computed Tomography
4
Metformin
4
Heavy Ion Radiotherapy
4
Exercise
4
Estramustine
4
luprolide acetate gel depot
3
darolutamide
3
Watchful Waiting
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Prostatic Neoplasms
×
Testosterone
×
Clear all
NCT05773183
2023-03-17
MMetdMH
Royal College of Surgeons, Ireland
Unknown
60 enrolled